These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 2839998

  • 21. Prolactin in childhood obsessive-compulsive disorder: clinical correlates and response to clomipramine.
    Hanna GL, McCracken JT, Cantwell DP.
    J Am Acad Child Adolesc Psychiatry; 1991 Mar; 30(2):173-8. PubMed ID: 2016218
    [Abstract] [Full Text] [Related]

  • 22. A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
    Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.
    Am J Psychiatry; 1990 Sep; 147(9):1209-15. PubMed ID: 2143637
    [Abstract] [Full Text] [Related]

  • 23. High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.
    Weizman A, Carmi M, Hermesh H, Shahar A, Apter A, Tyano S, Rehavi M.
    Am J Psychiatry; 1986 Mar; 143(3):335-9. PubMed ID: 3006522
    [Abstract] [Full Text] [Related]

  • 24. Sertraline in obsessive-compulsive disorder: a double-blind comparison with placebo.
    Jenike MA, Baer L, Summergrad P, Minichiello WE, Holland A, Seymour R.
    Am J Psychiatry; 1990 Jul; 147(7):923-8. PubMed ID: 2192564
    [Abstract] [Full Text] [Related]

  • 25. Noradrenergic and serotonergic neuroendocrine responses in prepubertal, peripubertal, and postpubertal rats pretreated with desipramine and sertraline.
    Carrey NJ, Dursun S, Clements R, Renton K, Waschbusch D, MacMaster FP.
    J Am Acad Child Adolesc Psychiatry; 2002 Aug; 41(8):999-1006; discussion 1007-9. PubMed ID: 12162636
    [Abstract] [Full Text] [Related]

  • 26. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS, Westenberg HG.
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [Abstract] [Full Text] [Related]

  • 27. Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder.
    Hewlett WA, Vinogradov S, Agras WS.
    J Clin Psychopharmacol; 1992 Dec; 12(6):420-30. PubMed ID: 1474179
    [Abstract] [Full Text] [Related]

  • 28. Seasonal effects in prolactin response to m-chlorophenylpiperazine challenge in obsessive-compulsive disorder.
    Grossman R, Cohen L, Rosen J, DeCaria C, Hollander E.
    Biol Psychiatry; 1996 Jun 01; 39(11):982-5. PubMed ID: 9162213
    [No Abstract] [Full Text] [Related]

  • 29. Serotonergic medications for sexual obsessions, sexual addictions, and paraphilias.
    Stein DJ, Hollander E, Anthony DT, Schneier FR, Fallon BA, Liebowitz MR, Klein DF.
    J Clin Psychiatry; 1992 Aug 01; 53(8):267-71. PubMed ID: 1386848
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Animal models in obsessive compulsive disorder.
    Olivier B.
    Int Clin Psychopharmacol; 1992 Jun 01; 7 Suppl 1():27-9. PubMed ID: 1517553
    [No Abstract] [Full Text] [Related]

  • 32. Mood-related obsessive-compulsive symptoms in a patient with bipolar affective disorder.
    Gordon A, Rasmussen SA.
    J Clin Psychiatry; 1988 Jan 01; 49(1):27-8. PubMed ID: 3335487
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder.
    Joel D, Doljansky J, Roz N, Rehavi M.
    Neuroscience; 2005 Jan 01; 130(1):25-36. PubMed ID: 15561422
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Combination of risperidone and serotonergic antidepressants in refractory obsessive-compulsive disorder].
    Salmerón JM, Alcántara AG, Barcia D.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 Jan 01; 26(6):399-402. PubMed ID: 9972593
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Update of the serotonergic hypothesis of obsessive compulsive disorder.
    Zohar J, Kindler S.
    Clin Neuropharmacol; 1992 Jan 01; 15 Suppl 1 Pt A():257A-258A. PubMed ID: 1386779
    [No Abstract] [Full Text] [Related]

  • 40. Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.
    Hadigan CM, Walsh BT, Buttinger C, Hollander E.
    Biol Psychiatry; 1995 Apr 15; 37(8):504-11. PubMed ID: 7619973
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.